Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Charles River Shareholder Notice

Newsfile March 24, 2023

Charles River Shareholder Action Reminder

Newsfile March 22, 2023

Charles River Shareholder Notice

Newsfile March 20, 2023

TOP RANKED ROSEN LAW FIRM Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

Newsfile March 19, 2023

Charles River Investor Alert

Newsfile March 19, 2023

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

PR Newswire March 18, 2023

Charles River Shareholder Notice

Newsfile March 17, 2023

Charles River Shareholder Action Reminder

Newsfile March 15, 2023

Charles River Investor Alert

Newsfile March 14, 2023

ROSEN, Top Ranked Investor Counsel, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

Newsfile March 14, 2023

Charles River Shareholder Notice

Newsfile March 13, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

PR Newswire March 13, 2023

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Business Wire March 13, 2023

Charles River Launches Apollo(TM), an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Business Wire March 13, 2023

Charles River Investor Alert

Newsfile March 12, 2023

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

PR Newswire March 11, 2023

Charles River Shareholder Action Reminder

Newsfile March 10, 2023

Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing

Business Wire March 9, 2023

Charles River Investor Alert

Newsfile March 8, 2023

Charles River Shareholder Action Reminder

Newsfile March 6, 2023